A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum-sensitive ovarian cancer (OC): CALYPSO study of the Gynecologic Cancer Intergroup (GCIG).
暂无分享,去创建一个
V. Gebski | I. Vergote | S. Pignata | P. Vasey | A. Reinthaller | J. Kaern | E. Pujade-Lauraine | S. Mahner | M. Heywood | A. Ferrero